RE:RE:RE:RE:Just a thought but---skier59 wrote: It's okay Johnny BJ we don't need anymore of your bosses money. Just tell Dr.Frosty to get ready to buy his 20 million warrants at 54 cents within the next 6 months. I remember you bashing the 5 year warrants when this PP was announced 4 1/2 years ago. Now we all know why, and they will either expire or Frosty will come up with the cash, and either one works for us Investors. We can complete our Phase2 in Canada and rely on the support of Canadian Investors, and Hospital and Government Institutions, to get our SP up before we need to start with the HIGH COST of doing a USA FDA Phase2. Also if I remember correctly, the FDA has in the past given approval to drugs that have been approved in our countries. So it makes one wonder, do we really need to complete a study in the USA? We can start with commercialization in Canada and ponder on that thought.
Are you sure Dr. Frost owns 20 million warrants? I thought it was under 5M. Those 19 million warrants won't expire until early Spring 2020 if I'm correct. Are you suggesting the clinical trial be conducted the slow poke way until then for lack of sufficient funds? And what if the deadline comes for cashing in those warrants and the sp is still below 54 cents or is that 57 cents? If a warrant holder is able to buy cheaper in the general market then they'll let their warrants expire without exercising them. Why take the gamble. Skier59, you don't sound as sure of the science as you pretend or else you would realize the dilution of a financial instrument would be inconsequential when weighed against the benefits of a speedier resolution of this trial. If the phase 2 bladder trial is what will define this company then the faster they can complete all stages of the trial the sooner shareholders can collect their bounty.